+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Statin use may improve clinicopathological characteristics and recurrence risk of invasive breast cancer



Statin use may improve clinicopathological characteristics and recurrence risk of invasive breast cancer



Medical Oncology 31(2): 835




(PDF emailed within 0-6 h: $19.90)

Accession: 055911514

Download citation: RISBibTeXText

PMID: 24381143

DOI: 10.1007/s12032-013-0835-x


Related references

Clinicopathological Risk Factors for an Invasive Breast Cancer Recurrence after Ductal Carcinoma In Situ -A Nested Case-Control Study. Clinical Cancer Research 24(15): 3593-3601, 2018

Incidence, Clinicopathological Risk Factors, Management and Outcomes of Nonmuscle Invasive Recurrence after Complete Response to Trimodality Therapy for Muscle Invasive Bladder Cancer. Journal of Urology 199(2): 407-415, 2017

Clinicopathological characteristics of metaplastic breast cancer - analysis of the basic immunohistochemical profile and comparison with other invasive breast cancer types. Breast 43: 135-141, 2018

Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone. Annals of Oncology 25(2): 339-345, 2015

Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study. Journal of the National Cancer Institute 103(19): 1461-1468, 2011

Statin Prescriptions and Breast Cancer Recurrence Risk: A Danish Nationwide Prospective Cohort Study. Breast Diseases: A Year Book Quarterly 23(3): 228-229, 2012

Mammographic features are associated with clinicopathological characteristics in invasive breast cancer. Anticancer Research 31(6): 2327-2334, 2011

Risk of ipsilateral breast tumor recurrence in primary invasive breast cancer following breast-conserving surgery with BRCA1 and BRCA2 mutation in China. Breast Cancer Research and Treatment 2019, 2019

Surgical margins and risk of locoregional recurrence in invasive breast cancer: an analysis of 10-year data from the Breast Cancer Treatment Quality Assurance Project. Breast 22(5): 839-844, 2014

Local recurrence after mastectomy for breast cancer: analysis of clinicopathological, biological and prognostic characteristics. Breast Cancer Research and Treatment 102(1): 61-73, 2006

Size of invasive breast cancer and risk of local recurrence after breast-conservation therapy. European Journal of Cancer 39(17): 2462-2469, 2003

Association of ErbB1-4 expression in invasive breast cancer with clinicopathological characteristics and prognosis. Breast Cancer 21(4): 472-481, 2015

Prognostic factors predicting recurrence in invasive breast cancer: An analysis of radiological and clinicopathological factors. Asian Journal of Surgery 2018, 2018

Basal subtype of invasive breast cancer is associated with a higher risk of true recurrence after conventional breast-conserving therapy. Breast Diseases: A Year Book Quarterly 23(3): 288-289, 2012

Basal subtype of invasive breast cancer is associated with a higher risk of true recurrence after conventional breast-conserving therapy. International Journal of Radiation Oncology, Biology, Physics 82(3): 1185-1191, 2012